HBV therapy nonadherence increases risk for liver-related complications

Medication nonadherence among patients with hepatitis B increased the risk for hepatocellular carcinoma, cirrhotic complications and all-cause mortality, according to recently published data.
“Adherence appears to be a key factor in minimizing [liver-related events (LRE)],” Neung Hwa Park, MD, PhD, from the University of Ulsan College of Medicine in the Republic of Korea, and colleagues wrote. “Considering that poor adherence increased the risk of LREs in this study, identifying an effective medical strategy to improve adherence to medication may substantially improve
Back to top button